17 January 2021 - increased offer

Regular readers will know that we have held on to our holding of AIM-listed healthcare group Clinigen as the share price has remained above the previously agreed offer price of 883p.  The company has announced today that it is now recommending an increased, final offer of 925p in cash per share.  We now expect this bid to go through and suggest that readers who hold the shares now ACCEPT THE OFFER

This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.

Already a member, log in HERE.

Tagged: